Skip to main content
. 2024 Mar 7;26:39. doi: 10.1186/s13058-024-01804-x

Table 1.

Characteristics of studies meeting search inclusion criteria

Author Year Country Participants Study design Data source Menopausal status Participant number Adiposity change information Breast cancer incidence by hormone receptor status Breast cancer incidence by race/ethnicity NOS score Study quality Measures of effect size Factors adjusted for in the model
Reported Enrollment Dates Reported funding source Reported conflicts of interest
Cao [21] 2019 China Asian (Chinese) Case-control The Chinese Wuxi Exposure and Breast Cancer Study Premenopausal

Cases: 254

Controls: 362

Weight (kg); Categorical (gain of ≤ 0, 0-5.6 [Ref], 5.7–9.5, 9.6–14, > 14); Continuous: per 5 kg weight change NA NA 7 Yes Yes Yes Odds ratio (OR) Age, education, age at menarche, age at first birth, parity, age at menopause, family history of breast cancer, previous benign breast disease, use of hormone replacement therapy, use of oral contraceptives, alcohol consumption, physical activity, height, weight at age 18.
Postmenopausal

Cases: 518

Controls: 517

Rosner [22] 2017 U.S.A. Americans Prospective cohort The Nurses’ Health Study cohort Premenopausal

Cohort: 6,894

Breast cancer cases: 758

Weight (kg); Categorical (loss of > 5, no change ≥-5, ≤ 5 [ref], gain of 5.1–10, 10.1–14.9, 15-19.9, ≥ 20); Continuous: per 30 kg weight change ER+/PR+; ER+/PR-; ER-/PR- NA 6 Yes Yes No Hazard ratio (HR); log-incidence model (i) duration of premenopause, (ii) duration postmenopause, (iii) type of menopause, natural or surgical (iv) parity and age at each birth, (v) current, past hormone therapy (HT) use, (vi) duration of HT use by type (estrogen only vs. estrogen plus progestin E&P), (vii) adult height, (viii) benign breast disease (BBD), (ix) alcohol intake, (x) family history of breast cancer in a first degree relative.
Postmenopausal

Cohort: 44,691

Breast cancer cases: 4,207

Wu [23] 2016 U.S.A. Asian Americans (Chinese, Japanese, Filipina) Case-control Los Angeles County Cancer Surveillance Program Premenopausal

Cases: 937

Controls: 1,025

Weight (kg); Categorical (gain of ≤ 3.64, 3.64–9.09 [ref], 9.09–14.1, 14.1–22.7, > 22.7); Continuous: per 5 kg weight change NA NA 5 Yes Yes Yes OR Age, education, income, years of residence in the United States among non-U.S. born, interviewer, age at menarche, parity, family history of breast cancer, and benign breast diseases, Asian ethnicity.
Postmenopausal

Cases: 1,133

Controls: 882

Age, education, income, years of residence in the United States among non-U.S. born, interviewer, age at menarche, parity, family history of breast cancer, benign breast disease, and type of menopause status

and age at menopause, Asian ethnicity.

Iqbal [24] 2015 Bangladesh Asian (Bangledeshis) Case-control Four hospitals in Bangladesh Premenopausal

Cases: 129

Controls: 129

Weight (kg); Continuous: per unit kg weight gain NA NA 6 Yes Yes Yes OR Reproductive, anthropometric, and socioeconomic factors.
Robinson [6] 2014 U.S.A. Black Americans, White Americans Case-control Carolina Breast Cancer Study Premenopausal

Cases: 848

Controls: 685

Weight (Ibs); Categorical (gain of ≤ 25 [ref], 26–54, ≥ 55) ER + or PR+; ER- and PR- Yes (Black Americans, White Americans) 5 Yes Yes Yes OR Age, age squared, family hx, alcohol, menarche, parity and age at 1st FTP composite, lactation, education, smoking, reference BMI.
Postmenopausal

Cases: 899

Controls: 818

Kawai [25] 2014 U.S.A. Americans Case-control Three-county Seattle-Puget Sound metropolitan area (King, Pierce, and Snohomish counties) Premenopausal

Cases: 1021

Controls: 940

BMI (kg/m2); Categorical (gain of < 0, 0–5 [ref], 5–10, ≥ 10); Continuous: per unit BMI change ER-/PR-/ HER2-; ER-/ HER2+; ER+ NA 6 Yes Yes Yes OR Age at reference, reference year, race/ethnicity, and age at first birth.
Canchola [7] 2012 U.S.A. Americans Prospective cohort California Teachers Study cohort Postmenopausal

Cohort: 52,642

Breast cancer cases: 2,839

Weight (Ibs); Categorical (loss of ≥ 10, stable≥-10, ≤ 10 [ref], gain of10-24, 25–39, ≥ 40); Continuous: per 10 lbs weight gain ER+/PR+; ER+/PR-; ER-/PR- NA 7 Yes Yes Yes Relative risks (RR; hazard rate ratios); Cox proportional hazards regression models

For ER+/PR+: age as the timescale, were stratified by age at baseline, and adjusted for age at menarche, parity, age at first full-term pregnancy, history of benign breast biopsy, family history of breast cancer, alcohol consumption, and use of hormone therapy, height, height.

For other subtypes of breast cancer, please see the original paper.

Ahn [8] 2007 U.S.A. Americans Prospective cohort National Institutes of Health -American Association of Retired Persons (NIH-AARP) Diet and Health Study Postmenopausal

Cohort: 99,039

Breast cancer cases: 2,111

Weight (kg); Categorical (gain of≥-7, -6.99 to -2, -1.9-1.9 [ref], 2-9.9, 10-19.9, 20-29.9, 30-39.9, 40-49.9, ≥ 50) NA NA 6 Yes Yes Yes RR; Cox proportional hazards regression

Age, age at menarche, age at menopause, age at first birth, parity, smoking, educational level, race, family history of breast cancer, fat intake, alcohol

consumption, oophorectomy, and physical activity, BMI at age 18 years, current BMI.

Palmer [43] 2007 U.S.A. Americans Prospective cohort The Black Women’s Health Study Premenopausal

Cohort: 42,538

Breast cancer cases: 490

Weight (kg); Categorical (gain of < 10 [ref], 10–14, 15–19, 20–24, ≥ 25) ER+/PR+; ER+/PR- or ER-/PR+; ER-/PR- Yes (Black Americans) 6 Yes Yes No

RR; Cox proportional hazards regression

models

Age, age at menarche, parity, age at first birth, vigorous activity, education, and family history of breast cancer, BMI at age 18 y.
Postmenopausal

Cohort: 9,542

Breast cancer cases: 443

Weight (kg); Categorical (gain of < 10 [ref], 10–14, 15–19, 20–24, ≥ 25) Age, age at menarche, parity, age at first birth, age at menopause, vigorous activity, education, and family history of breast cancer, BMI at age 18 y.
Weiderpass [26] 2004 Norway and Sweden Norwegian and Swedish Prospective cohort Central Population Register Premenopausal

Cohort: 99,717

Breast cancer cases: 733

BMI (kg/m2); Categorical (gain of < 0, 0-1.4 [ref], 1.5-4, > 4) NA NA 8 Yes Yes No RR; Cox proportional hazard models Age at enrolment, parity, age at first birth, oral contraceptive use, age at menarche, family history of breast cancer, total duration of breast-feeding, and country of residence, BMI at enrolment.
Wenten [27] 2002 U.S.A. Non-Hispanic White Americans, Hispanics Case-control New Mexico Women’s Health Study Premenopausal

Cases: 221

Controls: 314

Weight (kg); Categorical (gain of < 4 [ref], 4–7, 8–14, >14) ER+/PR+; ER-/PR- Yes (Non-Hispanic White Americans, Hispanics) 5 Yes Yes No OR Age, family history of breast cancer (1st degree relative), total METS, parity, oral contraceptive use, months of breast feeding, age at first full-term birth, and weight at 18.
Postmenopausal

Cases: 349

Controls: 391

Age, family history of breast cancer (1st degree relative), total METS, parity, oral contraceptive use, months of breast feeding, age at first full-term birth, HRT use, and weight at 18.
Morimoto [9] 2002 U.S.A. Americans Prospective cohort The women’s health initiative Postmenopausal

Cohort: 85,917

Breast cancer cases: 1,003

BMI (kg/m2); Categorical (gain of < 0, 0-3.5, 3.5–6.2, 6.2–9.7, > 9.7) NA NA 7 Yes Yes No

RR; Cox proportional hazards

regression

Age, education, age at menopause, parity, age at first birth, first degree family history of breast cancer, smoking, age at menarche, race, alcohol consumption, recreational physical activity, dietary energy.
Li [28] 2000 U.S.A. Americans Case-control Thirteen counties in western Washington State and participates in the Surveillance, Epidemiology and End Results Program (SEER) of the National Cancer Institute Postmenopausal

Cases: 478

Controls: 433

Weight (Ibs); Categorical (gain of < -10, -10 to 10 [ref], 11–30, 31–50, 51–70, > 70) NA NA 6 Yes Yes No OR Age, height, weight at age 18, family history of breast cancer, parity, use of hormone replacement therapy, and oral contraceptive use.
Magnusson [29] 1998 Sweden Swedish Case-control Swedish regional cancer registries Postmenopausal

Cases: 2,331

Controls: 2,214

Weight (kg); Categorical (gain of < 0, 0-9.5 [ref], 10-19.5, 20-29.5, ≥ 30) NA NA 7 Yes Yes No OR Age parity, age at first birth, age at menopause and use ofhormone replacement therapy.
Trentham-Dietz [30] 1997 U.S.A. Americans Case-control Wisconsin, Massachusetts (excluding the four counties that comprise metropolitan Boston), Maine, and New Hampshire Premenopausal

Cases: 1,608

Controls: 2,710

Weight (kg); Categorical (gain of < 0, 0-3.1 [ref], 3.2–6.7, 6.8–13.5, 13.6–78); Continuous: per 5 kg weight change NA NA 7 Yes Yes No OR Parity, age at first full-term pregnancy, age at menarche, family history of breast cancer, recent alcohol consumption, education, and height, weight at age 18 years.
Postmenopausal

Cases: 4,807

Controls: 6,134

Weight (kg); Categorical (gain of < 0, 0-5.8 [ref], 5.9–11.2, 11.3–18, 18.1–93); Continuous: per 5 kg weight change Parity, age at first full-term pregnancy, age at menarche, family history of breast cancer, recent alcohol consumption, education, age at menopause, and height, weight at age 18 years.
Taioli [31] 1995 U.S.A. Americans Case-control NA Premenopausal

Cases: 196

Controls: 191

Weight (kg); Categorical (gain of ≤ 0 [ref],1-9.9, 10-19.9, ≥ 20) NA NA 6 Yes No No OR Age, education, age at menarche, pregnancies, physical activity at the age 15–22 years.
Postmenopausal

Cases: 421

Controls: 340

Folsom [32] 1990 U.S.A. Americans Case-control State of Iowa Postmenopausal

Cases: 229

Controls: 1,839

Weight (kg); Categorical (gain of < 8.2, 8.2–17.3, > 17.3) NA NA 7 Yes Yes No OR Age